Hyperlipidemia, Familial Combined, 1 (FCHL1)

Hyperlipidemia, Familial Combined, 1, also known as hyperlipidemia, familial combined, susceptibility to, is related to hyperlipidemia, familial combined, 3 and lipid metabolism disorder. An important gene associated with Hyperlipidemia, Familial Combined, 1 is USF1 (Upstream Transcription Factor 1), and among its related pathways/superpathways is Familial hyperlipidemia type 1. The drugs Fenofibrate and Lovastatin have been mentioned in the context of this disorder. Affiliated tissues include heart.